Huapont Life Sciences Co.,Ltd. (SHE:002004)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Agrochemical New Materials Division	6.76B	6.65B	8.95B	8.19B	6.74B
Agrochemical New Materials Division Growth	1.62%	-25.69%	9.27%	21.53%	15.58%
Pharmaceutical Division	3.13B	-	3.03B	3.00B	2.78B
Pharmaceutical Division Growth	-	-	0.89%	7.99%	8.82%
Tourism Department	1.17B	1.09B	-	513.76M	585.29M
Tourism Department Growth	8.13%	-	-	-12.22%	-35.41%
Medicine Business	371.74M	265.62M	-	-	-
Medicine Business Growth	39.95%	-	-	-	-
Other Business Units	304.43M	628.92M	813.64M	723.25M	318.52M
Other Business Units Growth	-51.60%	-22.70%	12.50%	127.07%	-60.10%
Headquarters of The Group	86.35M	-	-	-	-
Intersegment Offset	-161.93M	-	-	-	-
Pharmaceutical Raw Materials	-	2.96B	-	-	-
Hospitality	-	-	438.79M	-	-
Technical and Other Services	-	-	-	-	307.97M
Total	11.66B	11.59B	13.23B	12.43B	10.73B
Total Growth	0.60%	-12.38%	6.45%	15.83%	6.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2019	FY 2019	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019	Jan 1, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Overseas	3.59B	3.73B	5.42B	4.66B	3.85B
Overseas Growth	-3.66%	-31.17%	16.35%	21.03%	1.96%
China	8.07B	7.87B	7.81B	7.77B	6.88B
China Growth	2.63%	0.65%	0.51%	12.92%	8.97%
Total	11.66B	11.59B	13.23B	12.43B	10.73B
Total Growth	0.60%	-12.38%	6.45%	15.83%	6.35%

Source: S&P Global Market Intelligence.